systemic%20lupus%20erythematosus%20(pediatric)
SYSTEMIC LUPUS ERYTHEMATOSUS (PEDIATRIC)
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be suspected when ≥2 organ systems are involved.
It is predominantly diagnosed in females of childbearing age, rarely diagnosed before 8 years old.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.
Drug Information

Indication: Eczema including atopic, infantile & discoid eczemas, prurigo nodularis, psoriasis (excluding widespread p...

Indication: Psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus & other condition which do not...

Indication: Moderate to severe forms of scalp psoriasis in ≥18 yr.

Indication: Short-term treatment of inflammatory & pruritic manifestations of moderate to severe corticosteroid-respon...

Indication: Adjuvant of a maintenance therapy & short-term administration in psoriatic arthritis, ankylosing spondylit...

Indication: Non-infected acute dermatitis or eczema, including infantile eczema, atopic eczema, contact & allergic der...

Indication: Short-term treatment of inflammatory &/or pruritis associated w/ acute & chronic corticosteroid-respon...

Indication: Inflammatory dermatoses that are normally responsive to topical corticosteroid therapy. Psoriasis. Eczema, pru...

Indication: Short-term treatment of inflammatory & pruritic manifestations of moderate to severe corticosteroid-respon...

2  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 5 days ago

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

Stephen Padilla, 6 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
3 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.